Literature DB >> 24413639

Live and let die: existential decision processes in a fatal disease.

Dorothée Lulé1, Sonja Nonnenmacher, Sonja Sorg, Johanna Heimrath, Martin Hautzinger, Thomas Meyer, Andrea Kübler, Niels Birbaumer, Albert C Ludolph.   

Abstract

Decisions and determinants of decisions to prolong or shorten life in the course of fatal diseases like ALS are poorly understood. Decisions and desire for hastened death of N = 93 ALS patients were investigated in a prospective longitudinal approach three times in the course of 1 year. Determinants of decisions were evaluated: quality of life (QoL), depression, feeling of being a burden, physical function, social support and cognitive status. More than half of patients had a positive attitude towards life-sustaining treatments and they had a low desire for hastened death. Of those with undecided or negative attitude, 10 % changed attitudes towards life-sustaining treatments in the course of 1 year. Patients' desire to hasten death was low and decreased significantly within 1 year despite physical function decline. Those with a high desire for hastened death decided against invasive therapeutic treatments. QoL, depression and social support were not predictors for vital decisions and remained stable. Feeling of being a burden was a predictor for decisions against life-supporting treatments. Throughout physical function loss, decisions to prolong life are flexibly adapted while desire to shorten life declines. QoL was stable and not a predictor for vital decisions, even though anticipated low QoL has been reported to be the reason to request euthanasia. In contrast, feeling of being a burden in decision making needs more attention in clinical counselling. Considering a patient's possible adaptation processes in the course of a fatal disease is necessary.

Entities:  

Mesh:

Year:  2014        PMID: 24413639     DOI: 10.1007/s00415-013-7229-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  35 in total

Review 1.  Amyotrophic lateral sclerosis.

Authors:  L P Rowland; N A Shneider
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

Review 2.  Threats to "informed" advance directives for the severely physically challenged?

Authors:  John R Bach
Journal:  Arch Phys Med Rehabil       Date:  2003-04       Impact factor: 3.966

3.  Measuring desire for death among patients with HIV/AIDS: the schedule of attitudes toward hastened death.

Authors:  B Rosenfeld; W Breitbart; K Stein; J Funesti-Esch; M Kaim; S Krivo; M Galietta
Journal:  Am J Psychiatry       Date:  1999-01       Impact factor: 18.112

4.  Legalized physician-assisted suicide in Oregon--the second year.

Authors:  A D Sullivan; K Hedberg; D W Fleming
Journal:  N Engl J Med       Date:  2000-02-24       Impact factor: 91.245

5.  Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis.

Authors:  Andrea Kübler; Susanne Winter; Albert C Ludolph; Martin Hautzinger; Niels Birbaumer
Journal:  Neurorehabil Neural Repair       Date:  2005-09       Impact factor: 3.919

Review 6.  Some difficult decisions in ALS/MND.

Authors:  David J Oliver; Martin R Turner
Journal:  Amyotroph Lateral Scler       Date:  2010-08

7.  Euthanasia and physician-assisted suicide among patients with amyotrophic lateral sclerosis in the Netherlands.

Authors:  Jan H Veldink; John H J Wokke; Gerrit van der Wal; J M B Vianney de Jong; Leonard H van den Berg
Journal:  N Engl J Med       Date:  2002-05-23       Impact factor: 91.245

8.  The dynamics of quality of life in ALS patients and caregivers.

Authors:  Abbey R Roach; Alyssa J Averill; Suzanne C Segerstrom; Edward J Kasarskis
Journal:  Ann Behav Med       Date:  2009-04-07

9.  Predicting survival of patients with amyotrophic lateral sclerosis at presentation: a 15-year experience.

Authors:  Paul H Gordon; François Salachas; Lucette Lacomblez; Nadine Le Forestier; Pierre-François Pradat; Gaelle Bruneteau; Alexis Elbaz; Vincent Meininger
Journal:  Neurodegener Dis       Date:  2012-08-21       Impact factor: 2.977

10.  Attitudes of patients with amyotrophic lateral sclerosis and their care givers toward assisted suicide.

Authors:  L Ganzini; W S Johnston; B H McFarland; S W Tolle; M A Lee
Journal:  N Engl J Med       Date:  1998-10-01       Impact factor: 91.245

View more
  20 in total

1.  [Decompressive surgery for ischemic stroke in the elderly. Pro].

Authors:  E Jüttler
Journal:  Nervenarzt       Date:  2015-12       Impact factor: 1.214

2.  Canadian best practice recommendations for the management of amyotrophic lateral sclerosis.

Authors:  Christen Shoesmith; Agessandro Abrahao; Tim Benstead; Marvin Chum; Nicolas Dupre; Aaron Izenberg; Wendy Johnston; Sanjay Kalra; Desmond Leddin; Colleen O'Connell; Kerri Schellenberg; Anu Tandon; Lorne Zinman
Journal:  CMAJ       Date:  2020-11-16       Impact factor: 8.262

3. 

Authors:  Christen Shoesmith; Agessandro Abrahao; Tim Benstead; Marvin Chum; Nicolas Dupre; Aaron Izenberg; Wendy Johnston; Sanjay Kalra; Desmond Leddin; Colleen O'Connell; Kerri Schellenberg; Anu Tandon; Lorne Zinman
Journal:  CMAJ       Date:  2020-11-16       Impact factor: 8.262

4.  Experience matters: neurologists' perspectives on ALS patients' well-being.

Authors:  Helena E A Aho-Özhan; Sarah Böhm; Jürgen Keller; Johannes Dorst; Ingo Uttner; Albert C Ludolph; Dorothée Lulé
Journal:  J Neurol       Date:  2017-01-24       Impact factor: 4.849

5.  Therapeutic decisions in ALS patients: cross-cultural differences and clinical implications.

Authors:  Peter M Andersen; Magdalena Kuzma-Kozakiewicz; Jürgen Keller; Helena E A Aho-Oezhan; Katarzyna Ciecwierska; Natalia Szejko; Cynthia Vázquez; Sarah Böhm; Gisela Badura-Lotter; Thomas Meyer; Susanne Petri; Katharina Linse; Andreas Hermann; Olof Semb; Erica Stenberg; Simona Nackberg; Johannes Dorst; Ingo Uttner; Ann-Cristin Häggström; Albert C Ludolph; Dorothée Lulé
Journal:  J Neurol       Date:  2018-05-04       Impact factor: 4.849

6.  Attitudes of Patients and Relatives Toward Disability and Treatment in Malignant MCA Infarction.

Authors:  Hermann Neugebauer; Matthias Schnabl; Dorothée Lulé; Peter U Heuschmann; Eric Jüttler
Journal:  Neurocrit Care       Date:  2017-04       Impact factor: 3.210

Review 7.  Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Chafic Karam; Nanette Joyce; Richard Bedlack; Gregory T Carter
Journal:  NeuroRehabilitation       Date:  2015       Impact factor: 2.138

8.  Perception of Emotional Facial Expressions in Amyotrophic Lateral Sclerosis (ALS) at Behavioural and Brain Metabolic Level.

Authors:  Helena E A Aho-Özhan; Jürgen Keller; Johanna Heimrath; Ingo Uttner; Jan Kassubek; Niels Birbaumer; Albert C Ludolph; Dorothée Lulé
Journal:  PLoS One       Date:  2016-10-14       Impact factor: 3.240

9.  Psychosocial adjustment to ALS: a longitudinal study.

Authors:  Tamara Matuz; Niels Birbaumer; Martin Hautzinger; Andrea Kübler
Journal:  Front Psychol       Date:  2015-09-14

Review 10.  Recent advances in amyotrophic lateral sclerosis.

Authors:  Nilo Riva; Federica Agosta; Christian Lunetta; Massimo Filippi; Angelo Quattrini
Journal:  J Neurol       Date:  2016-03-30       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.